Hematology

Refine Search

Acrotech urged to hurry up with confirmatory trial

Aurobindo Pharma subsidiary Acrotech Biopharma has been urged to work with the US Food and Drug Administration (FDA) to swiftly advance a confirmatory trial of 20 November 2023

Biotechnology

BeiGene notches up fourth EC approval for Brukinsa

BeiGene notches up fourth EC approval for Brukinsa 17 November 2023

Biotechnology

Kite punts millions more into Arcellx partnership

Kite punts millions more into Arcellx partnership 15 November 2023

Biotechnology

Hemogenyx lentivirus re-manufacturing completed

Hemogenyx lentivirus re-manufacturing completed 15 November 2023

Biotechnology

Vanflyta scores a first with EU approval

Vanflyta scores a first with EU approval 13 November 2023

November 2023 batch of EMA/CHMP recommendations 11 November 2023

Biotechnology

FDA approves first drug for rare inherited blood clotting disorder

FDA approves first drug for rare inherited blood clotting disorder 10 November 2023

Biotechnology

Another ADC foray for Bristol Myers Squibb

Another ADC foray for Bristol Myers Squibb 6 November 2023

Biotechnology

Roquefort boasts of NK cells activation in multiple cancer types

UK-based biotech Roquefort Therapeutics has announced that its mesodermal killer (MK) cell program has reached a significant milestone. 6 November 2023

Biotechnology

Pierre Fabre to acquire wider license for Ebvallo

Pierre Fabre to acquire wider license for Ebvallo 3 November 2023

Biotechnology

FDA AdCom largely supports safety of Vertex/CRISPR's exa-cel

FDA AdCom largely supports safety of Vertex/CRISPR’s exa-cel 1 November 2023

Biotechnology

Amgen reports 3rd-qtr sales in line with expectations, EPS beats

Amgen, Financial, Results, Third-quarter, 2023 1 November 2023

Pharmaceutical

Pfizer's pandemic windfall well and truly over, results show

31 October 2023

Biotechnology

Safety of sickle cell disease therapy may not be certain, say FDA scientists

In briefing notes released ahead of a key meeting on Tuesday, scientists at the US Food and Drug Administration describe uncertainty in the risks associated wit 30 October 2023

Biotechnology

Sobi rises on strong 3rd-qtr 2023 revenue and solid performance

Sobi rises on strong 3rd-qtr 2023 revenue and solid performance 30 October 2023

Biotechnology

Citius to spin off oncology division into separate public company

American critical care specialist Citius Pharma is to list its oncology subsidiary on the Nasdaq exchange, via merger with a special purpose acquisition company 25 October 2023

Biotechnology

Takeda takes Chinese rights for new hemophilia B gene therapy

Shanghai-based gene therapy company Belief BioMed (BBM) has out-licensed rights for the commercialization of its hemophilia candidate, BBM-H901, in China. 23 October 2023

Biotechnology

MHRA backs Tepkinly for diffuse large B-cell lymphoma in adults

MHRA backs Tepkinly for diffuse large B-cell lymphoma in adults 20 October 2023

Pharmaceutical

ESMO 2023: key data to look out for from oncology's big players

Nearly five months have passed since the Annual Meeting of the American Society of Clinical Oncology (ASCO) took place, and cancer-focused drugmakers are ready 19 October 2023

Pharmaceutical

Roche 9-month pharma sales strong, but demand for COVID-19 products down

Roche 9-month pharma sales strong, but demand for COVID-19 products down 19 October 2023

Previous page 6 7 8 91011 12 13 14 15 Next page

Hematology

Today's issue

Company Spotlight